Venture capital investment manager Deepbridge Capital today announces that it has seen a record year of Enterprise Investment Scheme (EIS) fundraising, with £29.4m deployed across 37 growth companies.

This represents an increase from 2019/20 and 2018/19 in which £21m and £28m were deployed respectively. Deepbridge manages the Deepbridge Technology Growth EIS and the Deepbridge Life Sciences EIS.

Deepbridge believes that its success this year – which is understood to contrast with the wider Enterprise Investment Scheme fundraising market – is down to the firm’s relationship with the advisory market and long-term sector focus on growth companies in the technology and life sciences sectors. For example, in the UK, the development of Covid treatments and vaccines has propelled the UK ahead as a leader in innovation across the life sciences spectrum and boosted investor interest in companies operating within it.

Click here to read the full article.



020 7071 3945


Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.